abstract |
The present invention relates to N- [4- (3-chloro-4-fluorophenylamino) -7- (3-morpholin-4-ylpropoxy) -quinazolin-6-yl] -acrylamide dihydrochloride Polymorphs / hydrates, methods for their preparation, and their use for the preparation of medicaments having irreversible tyrosine kinase inhibitory action. |